ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

DeVita Swearing In Schedule Aug. 8

August 1, 1980

Study tests a “truth” in radiation oncology, raises questions about anemia treatment.

October 24, 2003

Funding Opportunities

February 7, 2003

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980